Drug Profile
AG 1478
Latest Information Update: 20 Jul 2006
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Antivirals; Tyrphostins
- Mechanism of Action Protein tyrosine kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Human papillomavirus infections; Nasopharyngeal cancer
Most Recent Events
- 20 Jul 2006 No development reported - Preclinical for Nasopharyngeal cancer in China (unspecified route)
- 28 Aug 2001 Preclinical development for Nasopharyngeal cancer in China (Unknown route)
- 16 Feb 2001 No-Development-Reported for Human papillomavirus infections in Israel (Unknown route)